|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-2-26
|
|
pubmed:abstractText |
The molecular basis of neuroleptic malignant syndrome (NMS) is unclear, but clinical studies have noted a genetic predisposition. A recent genetic study suggested an association between NMS and the I A polymorphism in the dopamine D2 receptor (DRD2 ) gene. We further examined the association in a larger number of subjects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0955-8829
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
55-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12605103-Antipsychotic Agents,
pubmed-meshheading:12605103-Asian Continental Ancestry Group,
pubmed-meshheading:12605103-Gene Frequency,
pubmed-meshheading:12605103-Genotype,
pubmed-meshheading:12605103-Humans,
pubmed-meshheading:12605103-Japan,
pubmed-meshheading:12605103-Neuroleptic Malignant Syndrome,
pubmed-meshheading:12605103-Polymerase Chain Reaction,
pubmed-meshheading:12605103-Polymorphism, Genetic,
pubmed-meshheading:12605103-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:12605103-Receptors, Dopamine D2,
pubmed-meshheading:12605103-Schizophrenia,
pubmed-meshheading:12605103-Taq Polymerase
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene.
|
|
pubmed:affiliation |
Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan.
|
|
pubmed:publicationType |
Journal Article
|
